Alexander Heitkamp

Alexander Heitkamp

Auto-generated profile, based on publicly available information

Alexander Heitkamp

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Stroke
Verified
Journal Article
Open access
CHChristian Heitkamp
Christian Heitkamp
FFFabian Flottmann
Fabian Flottmann
TFTobias Djamsched Faizy
Tobias Djamsched Faizy
AHAlexander Heitkamp
Alexander Heitkamp
CTChristian Thaler
Christian Thaler
FIfor GSR-ET Investigators
for GSR-ET Investigators
BACKGROUND: The optimal anesthetic approach for patients with acute ischemic stroke with large vessel occlusion but low National Institutes of Health Stroke Scale receiving mechanical thrombectomy remains unclear. We aimed to evaluate the association of anesthetic strategies with procedural and clinical outcomes, hypothesizing that conscious sedation/local anesthesia (CS/LA) may offer a more favorable risk-benefit ratio than general anesthesia (GA). METHODS: Multicenter cohort study screening all thrombectomy patients prospectively enrolled in GSR-ET (German Stroke Registry-Endovascular Treatment) across 25 centers between 2015 and 2021. Patients with an admission National Institutes of Health Stroke Scale score of <6 and large vessel occlusion in the anterior circulation underwent 1:1 propensity score matching by their anesthetic strategy during mechanical thrombectomy (CS/LA versus GA). Outcome measures were an excellent functional outcome (modified Rankin Scale score of 0–1 at 90 days) and successful recanalization (modified Thrombolysis in Cerebral Infarction score of 2b-3). RESULTS: Of 13 082 thrombectomy cases, 814 had a National Institutes of Health Stroke Scale <6, of whom 36% received CS/LA and 64% received GA. Before matching, CS/LA patients were less often male (46% versus 54%; P =0.043), had lower National Institutes of Health Stroke Scale scores at admission (median, 3 versus 4; P =0.002), and the M1 segment of the middle cerebral artery was more often occluded (51% versus 39%; P <0.001). After matching, 582 patients were included, and baseline and imaging characteristics were balanced between CS/LA and GA. CS/LA and GA patients achieved similar rates of successful recanalization (85% versus 89%; P =0.14). However, complete recanalization (modified Thrombolysis in Cerebral Infarction score of 3) was less often observed in CS/LA patients (45% versus 61%; P <0.001; adjusted odds ratio, 0.44 [95% CI, 0.30–0.65]; P <0.001). CS/LA patients achieved more often excellent functional outcomes (59% versus 48%; P =0.005; adjusted odds ratio, 1.99 [95% CI, 1.34–2.95]; P =0.001). CONCLUSIONS: In thrombectomy patients with minor stroke, the rate of successful recanalization was comparable between CS/LA and GA. However, our results suggest a more favorable risk-benefit ratio of CS/LA, with an increased rate of excellent functional outcomes.

11 July 2025 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
AHAlexander Heitkamp
Alexander Heitkamp
SHSophie-Maria Hierholzer
Sophie-Maria Hierholzer
CHChristian Heitkamp
Christian Heitkamp
LWLaurens Winkelmeier
Laurens Winkelmeier
LMLukas Meyer
Lukas Meyer
F(For The German Stroke Registry -Endovascular Treatment (Gsr-Et)
For The German Stroke Registry -Endovascular Treatment (Gsr-Et)
Background and purpose: First pass (FP) recanalization, defined as achieving mTICI 2b or higher in a single thrombectomy attempt, has been linked to better functional recovery in acute ischemic stroke patients. This study aimed to investigate whether the benefits of FP are primarily driven by higher rates of complete reperfusion (mTICI 3) or by faster procedure times. Methods: Data from 3707 patients with middle cerebral artery occlusion and successful recanalization (mTICI 2b or higher) were extracted from the prospectively designed German Stroke Registry (2015–2021). Good functional outcomes were defined as a modified Rankin Scale (mRS) score of ≤ 2 at 90 days. Mediation analysis was used to evaluate the extent to which complete reperfusion (mTICI 3) and shorter groin puncture to recanalization time contributed to improved outcomes. Results: FP recanalization was associated with significantly better functional outcomes: 46.9% of FP patients achieved an mRS ≤ 2 compared to 37.2% in the multi-pass group. Mediation analysis showed that only 14% of the improved outcomes with FP were explained by higher mTICI 3 rates, while 37% were attributed to faster recanalization times. Conclusion: The improved outcomes associated with FP recanalization are primarily driven by the speed of reperfusion rather than the degree of complete recanalization. This highlights the importance of minimizing procedure times and the number of thrombectomy attempts. Strategies aimed at optimizing treatment workflows and improving device design to prioritize early and efficient reperfusion after the FP are critical to improving patient outcomes (ClinicalTrials.gov identifier: NCT03356392).

12 November 2025 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
EWEva‐Maria A. Wansing
Eva‐Maria A. Wansing
SWSebastian Georg Wicha
Sebastian Georg Wicha
PBPeter Bannas
Peter Bannas
AHAlexander Heitkamp
Alexander Heitkamp
ADAdrin Dadkhah
Adrin Dadkhah
CLClaudia PD Dr. Langebrake
Claudia PD Dr. Langebrake
Knowledge of the glomerular filtration rate (GFR) is mandatory when dosing renally eliminated drugs such as vancomycin. In clinical practice, different biomarkers and various equations are used to estimate GFR (eGFR), resulting in varying estimates. These variations may be explained by nonrenal factors, such as muscle status or glucocorticoid administration. This study aimed to evaluate the performance of different eGFR equations in terms of accuracy and precision compared to renal vancomycin clearance, including subgroup analyses for nonrenal confounders. We retrospectively analyzed data from 121 adult allogeneic hematopoietic stem cell transplant (allo‐HSCT) patients. All patients received vancomycin treatment including trough concentration therapeutic drug monitoring. The eGFR was calculated using eight equations and compared to the renal vancomycin clearance that was calculated using a pharmacokinetic model and served as the reference. Individual muscle status was determined by computed tomography scans. Median renal vancomycin clearance was 49 mL/minute/1.73 m 2 (range 24–96). All eight eGFR equations overestimated renal vancomycin clearance. The six (partially) creatinine‐based equations were significantly less accurate (bias: 24.0–62.8 mL/minute/1.73 m 2 ) than both cystatin C‐based equations (bias: 6.3–9.5 mL/minute/1.73 m 2 ). This decreased accuracy for creatinine‐based eGFR was more pronounced in patients with reduced muscle status or glucocorticoid medication. All CKD‐EPI equations and the Hoek equation were more precise with an IQR of the difference to renal vancomycin clearance ≤22.5 mL/minute/1.73 m 2 compared to ≥35.5 mL/minute/1.73 m 2 (Cockcroft‐Gault, MDRD). In conclusion, cystatin C‐based eGFR equations are preferable to creatinine‐based approaches for vancomycin dosing in allo‐HSCT patients.

15 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FSFelix Schlicht
Felix Schlicht
BTBogdana Tokareva
Bogdana Tokareva
HKHelge C. Kniep
Helge C. Kniep
LMLukas Meyer
Lukas Meyer
MBMatthias Bechstein
Matthias Bechstein
CTChristian Thaler
Christian Thaler
Background: Delayed cerebral ischaemia remains a major cause of secondary brain injury after aneurysmal subarachnoid haemorrhage (aSAH). Although computed tomography perfusion (CTP) is widely used for vasospasm surveillance, perfusion abnormalities are commonly reported only as present or absent, potentially overlooking the prognostic relevance of their extent. We investigated whether a territory-based perfusion burden score is associated with outcome more closely than binary perfusion deficit assessment. Methods: This retrospective single-centre cohort study included 179 patients with aSAH who underwent at least one CTP examination during hospitalization. CTP was performed according to clinical indication rather than at predefined time points; 448 examinations were evaluated. Two blinded neuroradiologists assigned one point per affected vascular territory (score range 0–12), and the maximum score during hospitalization was analysed. Outcomes were functional outcome at 6 months (modified Rankin Scale 0–2 versus 3–6), new cerebral infarction at discharge, and in-hospital mortality. Multivariable logistic regression models were built by forward selection from prespecified covariates (age, Hunt and Hess grade, modified Fisher grade, intracerebral haemorrhage, external ventricular drainage, and aneurysm treatment modality). Results: Territorial perfusion burden was independently associated with poor functional outcome (adjusted odds ratio 1.17 per point, 95% confidence interval 1.02–1.33) and new cerebral infarction (adjusted odds ratio 1.36 per point, 95% confidence interval 1.19–1.55). Any perfusion deficit was associated with new infarction (odds ratio 8.88, 95% confidence interval 3.31–23.87) but not with functional outcome. Conclusions: In this selected cohort under CTP surveillance, the extent of perfusion impairment was associated with functional outcome and infarction, whereas binary deficit assessment was associated with infarction only. These preliminary findings suggest that territorial perfusion burden may refine risk stratification, but prospective validation with standardized imaging time points is required before the score can be used as a prognostic tool.

9 October 2026 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
MKMalte Konrad
Malte Konrad
LMLukas Meyer
Lukas Meyer
GBGabriel Broocks
Gabriel Broocks
MBMatthias Bechstein
Matthias Bechstein
CTChristian Thaler
Christian Thaler
ABAlbrecht Bormann
Albrecht Bormann
Background: Intracranial stenting (ICS) is used as a rescue strategy in patients with failed reperfusion after endovascular thrombectomy (EVT). However, real-world data on clinical outcomes and safety remain limited. Methods: This retrospective analysis of prospectively collected data from the German Stroke Registry—Endovascular Treatment (GSR-ET) included patients with acute ischemic stroke due to middle cerebral artery (MCA) occlusion treated between June 2015 and December 2023. Patients undergoing ICS were compared with a 1:1 propensity score–matched cohort with failed reperfusion after EVT (final modified Thrombolysis in Cerebral Infarction [mTICI] score <2b) who received no further endovascular treatment. Functional, safety, and subgroup outcomes were assessed. Results: Among the 14,714 eligible patients, ICS was performed in 352 (2.4%). After matching, 218 patients undergoing ICS were compared with 218 controls with failed reperfusion. ICS was associated with a shift toward better 90-day functional outcomes in unadjusted (cOR 0.52, 95% CI 0.37–0.73; p <0.01) and adjusted analyses (acOR 0.41, 95% CI 0.29–0.59; p <0.01). Malignant MCA infarction occurred less frequently in the ICS group (1% vs. 8%; p <0.01), as did 90-day mortality (26% vs. 37%; p =0.02). Symptomatic intracranial hemorrhage did not differ between groups (4% vs. 5%; p =0.63). Conclusions: Patients treated with ICS had a shift toward better functional outcomes and lower 90-day mortality than those with failed reperfusion who received no further endovascular treatment. Symptomatic intracranial hemorrhage did not differ between groups. These findings support further investigation of ICS after failed EVT, although randomized studies are needed to determine its efficacy and safety.

13 March 2026 in Clinical Neuroradiology
Verified
Journal Article
Open access
PDF file
CHChristian Heitkamp
Christian Heitkamp
UHUta Hanning
Uta Hanning
AHAlexander Heitkamp
Alexander Heitkamp
LMLuca Meucci
Luca Meucci
SKSusan Klapproth
Susan Klapproth
G(German Stroke Registry – Endovascular Treatment (Gsr-Et)
German Stroke Registry – Endovascular Treatment (Gsr-Et)
Purpose: The treatment effect of mechanical thrombectomy in patients with mild stroke symptoms and large vessel occlusion remains unclear. Furthermore, it is uncertain whether achieving complete reperfusion (modified Thrombolysis in Cerebral Infarction [mTICI] 3) offers additional clinical benefit compared to incomplete reperfusion (mTICI 2b) in patients with mild stroke. Methods: In this retrospective, multicenter analysis, all patients enrolled in the German Stroke Registry—Endovascular Treatment between 2015 and 2023 ( n = 18,069) were evaluated. The study included patients with a National Institutes of Health Stroke Scale (NIHSS) score of < 6 and anterior circulation large vessel occlusion. Clinical outcomes were compared between mTICI 2b and mTICI 3. The primary endpoint was excellent functional outcome at 90 days, defined as a modified Rankin Scale (mRS) score of 0–1. Results: Of the 747 included patients, 37% achieved mTICI 2b and 63% mTICI 3. An excellent functional outcome was observed at similar rates in both groups (mTICI 2b: 59% vs. mTICI 3: 60%; P = 0.83; adjusted OR: 0.96 [95% CI: 0.66–1.40]; P = 0.84). The rates of symptomatic intracranial hemorrhage (4% vs. 3%; P = 0.36) and 90-day mortality (10% vs. 7%; P = 0.26; adjusted OR: 0.80 [95% CI: 0.42–1.50]; P = 0.49) were also comparable between the two groups. Conclusion: Among thrombectomy patients with mild stroke, complete reperfusion was not associated with better functional outcomes than incomplete reperfusion. These findings suggest that mTICI 2b may be an acceptable final angiographic result and raise questions about the risk-benefit ratio of additional retrieval maneuvers aimed at achieving mTICI 3.